The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Valneva Austria competitive analysis

Loading summary...

Latest oppositions filed by Valneva Austria

Explore patent oppositions filed by Valneva Austria against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3564378
Immunogenic CompositionGLAXOSMITHKLINEJul 25, 2024
EP3138916
Immunogenic CompositionGLAXOSMITHKLINEMar 16, 2020

Latest patents of Valneva Austria opposed by its competitors

Explore Valneva Austria's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3785730
Apr 24, 2024Aluminium Compounds For Use In Therapeutics And Vaccines1
EP3393510
Feb 22, 2023Zika Virus Vaccine1
EP3269386
Sep 14, 2022Aluminium Compounds For Use In Therapeutics And Vaccines1
EP3106176
Oct 11, 2017Aluminium Compounds For Use In Therapeutics And Vaccines1

Latest PTAB cases involving Valneva Austria

Discover the latest PTAB cases involving Valneva Austria, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Valneva Austria

IPR2025-00776Mar 31, 2025VALNEVA AUSTRIATAKEDA VACCINESTrial Instituted
IPR2023-00354Dec 27, 2022TAKEDA VACCINESVALNEVA AUSTRIAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Valneva Austria with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VALNEVA AUSTRIA2411
GLAXOSMITHKLINE29112812
MAIWALD136 - - -
TAKEDA VACCINES - - 11